Aficamten treatment was associated with significant improvements in exercise capacity and symptoms compared with metoprolol in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM), according to late-breaking research presented in a Hot Line session today at ESC Congress 2025 and simultaneously published in New England Journal of Medicine.
Equine Osteopathy | London School of Osteopathy
Equine Osteopathy | London School of Osteopathy Written by London School of Osteopathy November 27, 2025 Equine osteopathy: An Introduction